AlexNet for Image-Based COVID-19 Diagnosis
M Tang, Y Peng, S Wang, S Chen, Y Zhang - International Conference on …, 2023 - Springer
The medical community is working harder to develop quick and accurate methods of
diagnosing the virus in response to the COVID-19 pandemic. The speed and efficiency of …
diagnosing the virus in response to the COVID-19 pandemic. The speed and efficiency of …
[HTML][HTML] 重症新型冠状病毒肺炎患者的死亡风险因素分析
吴丹， 胡雪军， 吴狄， 于明哲， 黄太平， 赵霄君… - Advances in Clinical …, 2023 - hanspub.org
目的: 分析重症新型冠状病毒肺炎患者的死亡风险因素. 方法: 本研究为一项回顾性病例对照研究
. 连续性收集2022 年10 月至2023 年4 月西京医院, 空军第九八六医院确诊为重症新冠肺炎的 …
. 连续性收集2022 年10 月至2023 年4 月西京医院, 空军第九八六医院确诊为重症新冠肺炎的 …
[PDF][PDF] Association of COVID-19 with Features of the Peripheral Hemogram Among Cancer Patients Undergoing Chemotherapy
JY Su, ZJ Guo, YH Liu, QM Li, YJ Li… - Eurasian Journal of …, 2023 - academia.edu
Objectives: Future pandemics involving COVID-19 or other respiratory disorders may pose
risks to treatment outcomes among cancer patients on chemotherapy. Here we explored …
risks to treatment outcomes among cancer patients on chemotherapy. Here we explored …
Field-effect Transistor Biosensors for Rapid SARS-CoV-2 Detection
A Ibijbijen, F Besbes, H Korri-Youssoufi - 2024 - books.rsc.org
The COVID-19 pandemic has an unprecedented global effect and brought about a
significant change in the healthcare industry. With the increasing demand for accurate and …
significant change in the healthcare industry. With the increasing demand for accurate and …
[引用][C] Clinical features, immune response, and virological factors associated with SARS-CoV-2 infection outcomes
S Salto Alejandre - 2023
Evaluation of serological and hematological parameters in donors of SARS-CoV-2 convalescent plasma in respect of periods of donation.
M Stanek, A Leśków… - Acta Haematologica …, 2024 - search.ebscohost.com
Introduction: The COVID-19 pandemic has had a major impact on the health and lives of
many people worldwide. According to World Health Organization (WHO) global data, 774 …
many people worldwide. According to World Health Organization (WHO) global data, 774 …
[PDF][PDF] Validation of Extracellular Vesicles expressing SARS-CoV-2 Spike protein (S-EVs) as a model of virus like particle for possible theragnostic applications
R Verta - 2024 - iris.unito.it
ABSTRACT Coronavirus disease 2019 (COVID-19), caused by the highly contagious severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has had a devastating global …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has had a devastating global …
Examining efficacy and safety of ethyl acetate extract from Allium hirtifolium as complementary therapy in COVID-19: A randomized, multicenter, controlled clinical trial
M Amin, M Pouladzadeh, MJ Yadyad… - Avicenna Journal of …, 2024 - ajp.mums.ac.ir
Objective: Given the apparent life-threatening nature of COVID-19, finding an effective
treatment is under investigation. Materials and Methods: We assessed effect of shallomin …
treatment is under investigation. Materials and Methods: We assessed effect of shallomin …
A Method of Identifying Treatment Modalities Related to COVID-19 from PubMed Abstracts
P Donsena, J Polpinij… - 2023 7th …, 2023 - ieeexplore.ieee.org
In the past three to four years, COVID-19, a highly contagious disease caused by a novel
coronavirus, has resulted in a significant number of fatalities. Numerous interventions have …
coronavirus, has resulted in a significant number of fatalities. Numerous interventions have …
Trajectories and predictive significance of inflammatory parameters for clinical outcome in COVID-19 patients treated with tocilizumab
S Gliga, P Massion, C Ackermann, C de Angelis… - 2024 - researchsquare.com
Purpose: The IL-6 receptor inhibitor tocilizumab reduces mortality and morbidity in severe
cases of COVID-19 through its effects on hyperinflammation and was approved as adjuvant …
cases of COVID-19 through its effects on hyperinflammation and was approved as adjuvant …